Bristol Myers Squibb

ForLifeX is located in Melbourne, Victoria 3000, and currently appears to be in maintenance mode, indicating that updates or changes may be underway. The site is expected to be available soon, providing services or information relevant to its users. Visitors are encouraged to be patient as the platform prepares for its upcoming features or enhancements. Further details about the offerings will be accessible once the maintenance period concludes. Generated from the website

ENA Respiratory is a clinical-stage pharmaceutical company based in Melbourne, Victoria, focused on developing antiviral host defense enhancers aimed at preventing severe complications from respiratory viral infections in vulnerable populations. Their lead product, INNA051, is a first-in-class TLR2/6 agonist designed for convenient self-administration via a nasal spray, promoting the body's natural defenses against respiratory viruses. The company is led by an experienced team dedicated to improving the lives of at-risk populations while minimizing the burden on healthcare systems. INNA051 has shown effectiveness against multiple respiratory viruses and is supported by a favorable safety profile for seasonal use, allowing for a weekly dosing regimen. Generated from the website